P Farci

953 total citations
29 papers, 712 citations indexed

About

P Farci is a scholar working on Hepatology, Epidemiology and Organic Chemistry. According to data from OpenAlex, P Farci has authored 29 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 14 papers in Epidemiology and 5 papers in Organic Chemistry. Recurrent topics in P Farci's work include Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease Diagnosis and Treatment (8 papers). P Farci is often cited by papers focused on Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease Diagnosis and Treatment (8 papers). P Farci collaborates with scholars based in Italy, France and United Kingdom. P Farci's co-authors include O Crivelli, Purcell Rh, C Lavarini, S Macagno, F. Caredda, Marcello Aragona, Mario Rizzetto, E Maran, Giuseppina Sanna and Bernardetta Busonera and has published in prestigious journals such as The Lancet, Blood and Hepatology.

In The Last Decade

P Farci

29 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Farci Italy	12	232	205	204	153	76	29	712
Vladimir T. Valuev-Elliston Russia	13	246 1.1×	113 0.6×	285 1.4×	83 0.5×	174 2.3×	40	764
Coralie Pallier France	15	309 1.3×	298 1.5×	182 0.9×	66 0.4×	136 1.8×	22	933
Rozenn Brillet France	15	451 1.9×	503 2.5×	234 1.1×	123 0.8×	179 2.4×	25	986
Niki Vassilaki Greece	17	344 1.5×	464 2.3×	194 1.0×	59 0.4×	169 2.2×	54	888
Masayo Hashimoto Japan	12	186 0.8×	188 0.9×	121 0.6×	31 0.2×	61 0.8×	42	623
Sarah Welbourn United States	12	193 0.8×	140 0.7×	158 0.8×	10 0.1×	97 1.3×	20	550
Judy S. Mathew United States	10	123 0.5×	80 0.4×	220 1.1×	103 0.7×	206 2.7×	13	466
Joachim Seipelt Austria	17	181 0.8×	30 0.1×	308 1.5×	47 0.3×	226 3.0×	22	972
Shin-ichiro Hattori Japan	16	114 0.5×	44 0.2×	204 1.0×	128 0.8×	269 3.5×	36	715

Countries citing papers authored by P Farci

Since Specialization

Citations

This map shows the geographic impact of P Farci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Farci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Farci more than expected).

Fields of papers citing papers by P Farci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Farci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Farci. The network helps show where P Farci may publish in the future.

Co-authorship network of co-authors of P Farci

This figure shows the co-authorship network connecting the top 25 collaborators of P Farci. A scholar is included among the top collaborators of P Farci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Farci. P Farci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Briguglio, Irene, Roberta Loddo, Erik Laurini, et al.. (2015). Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives. European Journal of Medicinal Chemistry. 105. 63–79. 37 indexed citations

Sanna, Giuseppina, P Farci, Bernardetta Busonera, et al.. (2015). Antiviral properties from plants of the Mediterranean flora. Natural Product Research. 29(22). 2065–2070. 24 indexed citations

Tonelli, Michele, Federica Novelli, Bruno Tasso, et al.. (2014). Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents. Bioorganic & Medicinal Chemistry. 22(17). 4893–4909. 77 indexed citations

Loddo, Roberta, Irene Briguglio, Paola Corona, et al.. (2014). Synthesis and antiviral activity of new phenylimidazopyridines and N-benzylidenequinolinamines derived by molecular simplification of phenylimidazo[4,5-g]quinolines. European Journal of Medicinal Chemistry. 84. 8–16. 14 indexed citations

Cottiglia, Filippo, Laura Casu, Marco Leonti, et al.. (2012). Cytotoxic Phloroglucinols from the Leaves of Myrtus communis. Journal of Natural Products. 75(2). 225–229. 58 indexed citations

Corona, Paola, Mario Loriga, Antonio Carta, et al.. (2012). 5-Acetyl-2-arylbenzimidazoles as antiviral agents. Part 4. European Journal of Medicinal Chemistry. 53. 83–97. 25 indexed citations

Tonelli, Michele, Bruno Tasso, Federica Novelli, et al.. (2011). Acridine derivatives as anti-BVDV agents. Antiviral Research. 91(2). 133–141. 59 indexed citations

Marcellin, Patrick, Teerha Piratvisuth, Maurizia Rossana Brunetto, et al.. (2009). 924 INCREASING RATES OF HBsAg CLEARANCE AND SEROCONVERSION IN PATIENTS WITH HBeAg-NEGATIVE DISEASE TREATED WITH PEGINTERFERON ALFA-2A ± LAMIVUDINE: RESULTS OF 5-YEAR POST-TREATMENT FOLLOW UP. Journal of Hepatology. 50. S336–S336. 20 indexed citations

Farci, P, et al.. (2007). Treatment of chronic hepatitis D. Journal of Viral Hepatitis. 14(s1). 58–63. 24 indexed citations

10.

Zeuzem, Stefan, et al.. (2003). 106 International, multicenter, randomized, controlled study for the treatment of patients with chronic hepatitis C and persistently normal ALT levels with peginterferon alfa-2A (40KD) (PEGASYS®) and ribavirin (copegus®). Hepatology. 38. 208–208. 22 indexed citations

11.

Farci, P. (1993). Prevention of HCV infection in chimpanzees following antibody-mediated in vitro neutralization. Hepatology. 18(4). A111–A111. 5 indexed citations

12.

Farci, P. (1993). LACK OF PROTECTIVE IMMUNITY AGAINST REINFECTION WITH HEPATITIS-C VIRUS. The Pediatric Infectious Disease Journal. 12(5). 422–422. 10 indexed citations

13.

Fattovich, Giovanna, P Farci, L. Brollo, et al.. (1990). Favourable response to lymphoblastoid interferon of anti-HBe positive chronic hepatitis type B. Journal of Hepatology. 11. S21–S21. 1 indexed citations

14.

Farci, P, et al.. (1990). [The presence of nucleotide sequences of the hepatitis B virus in the serum of HBsAg-negative blood donors in Sardinia].. PubMed. 81(4). 283–6. 1 indexed citations

15.

Marongiu, Francesco, et al.. (1989). Evidence for a Relationship between High Fibrinogen Levels and Decreased Thrombin Activity in vivo in Elderly Subjects. Pathophysiology of Haemostasis and Thrombosis. 19(2). 91–93. 2 indexed citations

16.

Marongiu, Francesco, A.M. Mamusa, Matteo Conti, et al.. (1989). Thrombin Activity and Oral Anticoagulant Therapy: A Preliminary Study. Pathophysiology of Haemostasis and Thrombosis. 19(3). 142–146. 5 indexed citations

17.

Fattovich, G., P Farci, L. Brollo, et al.. (1989). Anti-HBe and HBV-DNA positive chronic hepatitis B: Response to interferon therapy. Journal of Hepatology. 9. S29–S29. 2 indexed citations

18.

Farci, P, et al.. (1989). Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood. 73(1). 17–19. 86 indexed citations

19.

Aragona, Marcello, S Macagno, F. Caredda, et al.. (1987). Serological response to the hepatitis dSerological response to the hepatitis delta virus in hepatitis D.. The Lancet. 1. 478–480. 208 indexed citations

20.

Farci, P, et al.. (1983). Epidemiology and clinical course of delta infection in Britain.. PubMed. 143. 219–23. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact